Trial intelligence / Profile preview

The Swiss Glucose Variability Study

NCT01426737Phase 4Unknown

Sponsor
University of Zurich
Start
Apr 2011
Primary completion
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by University of Zurich. Status: unknown.

02

Drugs

vildagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01426737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01426737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call